Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week
Big-pharma stocks have generally had an outstanding week thus far. Through Thursday's closing bell, Bristol Myers Squibb (NYSE: BMY) shares have tracked higher by a respectable 8.2%, Pfizer (NYSE: PFE) stock is up by an eye-popping 17.5%, and Eli Lilly (NYSE: LLY) has seen its equity rise by a healthy 14.6%, according to data from S&P Global Market Intelligence.
As a result, Pfizer and Lilly's shares are both trading close to their 52-week highs right now, while Bristol's stock has regained a fair amount of lost ground after trending lower for most of 2021. These three elite pharma stocks have raced higher this week due to a mix of market-wide and company-specific factors.
Image source: Getty Images.
Source Fool.com
